According to Teva Pharmaceutical Industries's latest financial reports the company's current revenue (TTM) is $15.84 B. In 2022 the company made a revenue of $14.92 B a decrease over the years 2021 revenue that were of $15.87 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $15.84 B | 6.18% |
2022 | $14.92 B | -6.01% |
2021 | $15.87 B | -4.68% |
2020 | $16.65 B | 1.52% |
2019 | $16.40 B | -12.97% |
2018 | $18.85 B | -16% |
2017 | $22.44 B | 2.48% |
2016 | $21.90 B | 11.45% |
2015 | $19.65 B | -3.06% |
2014 | $20.27 B | -0.21% |
2013 | $20.31 B | -0.01% |
2012 | $20.31 B | 10.95% |
2011 | $18.31 B | 13.59% |
2010 | $16.12 B | 15.99% |
2009 | $13.89 B | 25.39% |
2008 | $11.08 B | 17.83% |
2007 | $9.40 B | 11.89% |
2006 | $8.40 B | 60.15% |
2005 | $5.25 B | 9.41% |
2004 | $4.79 B | 46.47% |
2003 | $3.27 B | 30.09% |
2002 | $2.51 B | 21.24% |
2001 | $2.07 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Novartis NVS | $51.01 B | 221.92% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | 269.16% | ๐บ๐ธ USA |
Sanofi SNY | $50.35 B | 217.81% | ๐ซ๐ท France |
Merck MRK | $60.11 B | 279.36% | ๐บ๐ธ USA |
AstraZeneca AZN | $45.81 B | 189.10% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $37.84 B | 138.86% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | $3.28 B | -79.28% | ๐ฎ๐ณ India |